Authors
Muthyala Harshini, Nirmala Jonnavithula, Archana Pathy, Medoji Sarath Chandra, Singam Geetha, Ramakrishna Ravula
Published in
Revista espanola de anestesiologia y reanimacion. Pages 502237. Nov 14, 2026. Epub Nov 14, 2026.
Abstract
Racemic bupivacaine is the reference agent for subarachnoid block, but its cardiotoxic potential has prompted interest in its S-enantiomer, levobupivacaine. We compared intrathecal hyperbaric levobupivacaine plus fentanyl with hyperbaric bupivacaine plus fentanyl in lower limb orthopaedic surgery.
Eighty patients with American Society of Anesthesiologists physical status I or II, aged 18 to 60 years, undergoing elective lower limb orthopaedic surgery were randomly allocated to 12.5 mg of 0.5% hyperbaric levobupivacaine with 25 µg fentanyl (Group A) or 12.5 mg of 0.5% hyperbaric bupivacaine with 25 µg fentanyl (Group B). The primary outcome was duration of analgesia; secondary outcomes were block characteristics, haemodynamic variables, and complications.
Seventy-nine patients were analysed (Group A = 40, Group B = 39). Duration of analgesia was comparable (192.3 ± 40.0 vs. 181.6 ± 40.6 min; mean difference 10.7 min, 95% CI - 7.4 to 28.7; p = 0.243). Group A had slower onset of complete motor block and longer time to peak sensory level (p < 0.05), but faster motor recovery (76.4 ± 14.1 vs. 119.0 ± 14.8 min; p < 0.001). Postoperative pain scores and rescue analgesic requirements were lower in Group A, and complications occurred only in Group B (p = 0.005). Haemodynamic profiles were comparable.
Hyperbaric levobupivacaine with fentanyl has a slower onset, a comparable duration of analgesia, and faster motor recovery than hyperbaric bupivacaine with fentanyl, and is an effective alternative for lower limb orthopaedic surgery.
PMID:
43034043
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 3
- Comments 0